Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.59    -0.31 (-10.69%)
Bid:
2.60
Ask:
2.91
Spread: 0.31 (11.923%)
Market Cap: £4.73m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

Board Changes

18 May 2016 07:00

RNS Number : 5341Y
Nanoco Group PLC
18 May 2016
 

For immediate release

18 May 2016

 

 

 

 

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

Board Changes

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, announces that its Chairman, Tony Clinch, has resigned as a director after six years on the Company's Board, a period during which he has led the Company through key corporate milestones including the move from AIM to the Official List and from an exclusive to a non-exclusive commercialisation strategy in the display market.

Tony joined Nanoco's Board as a Non-Executive Director in March 2010 and was appointed Chairman in April 2013.

Chris Richards, who joined Nanoco's Board as a Non-Executive Director in November 2015, has been appointed Chairman.

The above Board changes are taking place with immediate effect.

Michael Edelman, Nanoco's Chief Executive Officer, said: "On behalf of the Board, I would like to express sincere thanks to Tony Clinch for the major contribution he has made to Nanoco's development in the past six years, most recently as Chairman. In this role, he has provided wise counsel on the commercial transition of the Company in the display market, opening up new commercial opportunities through a non-exclusive licensing strategy. We thank Tony for his dedication to Nanoco and wish him well in his future endeavours.

"I would also like to welcome Chris Richards, a Non-Executive Director for the past six months, to the role of Chairman. I'm confident that he will build on the platform that Tony has created, and guide us in the exploitation of Nanoco's world-leading technology through multiple channels in the display market and in our other target markets."

 

 

For further information, please contact:

 

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

David Blain, Chief Financial Officer

Caroline Watson, Investor Relations Manager

cwatson@nanocotechnologies.com

 

Tel: + 44 (0) 7799 897357

Canaccord Genuity - Joint Broker

Tel: +44 (0) 20 7523 8000

Simon Bridges

Cameron Duncan

Mark Whitmore

Liberum - Joint Broker

Tel: +44 (0) 20 3100 2000

Neil Patel

Richard Bootle

Steven Tredget

Buchanan

Tel: +44 (0) 20 7466 5000

Mark Court / Sophie Cowles / Stephanie Watson

 

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nanomaterials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, it has a non-exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

 

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEAESXFAEKEAF
Date   Source Headline
13th Aug 201311:45 amRNSHolding(s) in Company
5th Aug 20136:09 pmRNSTotal Voting Rights
5th Aug 20131:19 pmRNSHolding(s) in Company
26th Jul 20135:14 pmRNSDirector's Dealings
9th Jul 20131:58 pmRNSHolding(s) in Company
25th Jun 20133:30 pmRNSHolding(s) in Company
17th Jun 20137:00 amRNSHolding(s) in Company
12th Jun 20137:00 amRNSBlocklisting Interim Review
31st May 20132:43 pmRNSHolding(s) in Company
31st May 20139:22 amRNSHolding(s) in Company
15th May 20134:45 pmRNSHolding(s) in Company
14th May 20135:52 pmRNSHolding(s) in Company
9th May 201312:30 pmRNSRelocation of CEO to the US and Director Dealings
2nd May 20137:00 amRNSSigns Follow-on Agreement
29th Apr 20137:00 amRNSBoard Changes
24th Apr 20137:00 amRNSHolding(s) in Company
11th Apr 20134:46 pmRNSHolding(s) in Company
11th Apr 20137:00 amRNSHolding(s) in Company
28th Mar 20132:00 pmRNSAppointment of Joint Broker
27th Mar 20132:20 pmRNSHolding (s) in Company
18th Mar 20137:00 amRNSInterim Results
15th Feb 20132:08 pmRNSHolding(s) in Company
14th Feb 20131:00 pmRNSHolding(s) in Company
12th Feb 20139:49 amRNSHolding(s) in Company
6th Feb 20137:00 amRNSAppointment of Key Business Development Executives
29th Jan 20134:18 pmRNSHolding(s) in Company
28th Jan 20136:06 pmRNSHolding(s) in Company
24th Jan 20135:51 pmRNSHolding(s) in Company
23rd Jan 20137:00 amRNSLicensing Agreement with Dow Chemical
21st Jan 20137:00 amRNSNotification of Interim Results
11th Jan 20138:59 amRNSHolding(s) in Company
10th Jan 20131:19 pmRNSHolding(s) in Company
20th Dec 20127:00 amRNSSigns further agreement with Tokyo Electron
14th Dec 201210:25 amRNSResult of AGM
14th Dec 20127:00 amRNSAGM Statement
12th Dec 20123:37 pmRNSBlock Listing Application
4th Dec 20127:00 amRNSExercise of Options
12th Nov 20127:00 amRNSPosting of Annual Report & Accounts
23rd Oct 20127:00 amRNSGrant of Options
19th Oct 201212:43 pmRNSDirectors' Dealings and Exercise of Options
15th Oct 20127:00 amRNSPreliminary Results
5th Oct 20127:00 amRNSFollow-on Lighting Agreement
5th Sep 20127:00 amRNSNotification of Preliminary Results
20th Aug 20127:00 amRNSWins Government Grants
1st Aug 20127:00 amRNSTotal Voting Rights
31st Jul 20127:00 amRNSSigns Joint Development Agreement
27th Jul 20127:00 amRNSExercise of Options
25th Jun 20127:00 amRNSChange of Adviser
9th May 20127:00 amRNSAchieves US$2m Milestone
2nd Apr 20122:15 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.